Company profile: diaDexus
1.1 - Company Overview
Company description
- Provider of novel, patent-protected diagnostic products with high clinical value, focused on the discovery, development and commercialization of diagnostics. The company's lead product, the PLAC Test, measures Lp-PLA2 (lipoprotein-associated phospholipase A2), a vascular-specific inflammatory enzyme.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to diaDexus
Morphogen-IX
HQ: United Kingdom
Website
- Description: Provider of drug discovery developing bone morphogenetic proteins as a novel therapy for pulmonary arterial hypertension, a severe, life-limiting disease affecting lung blood vessels and leading to heart failure; founded in 2015 by Index Ventures.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Morphogen-IX company profile →
FoxHollow Technologies
HQ: United States
Website
- Description: Provider of medical devices for the treatment of peripheral artery disease (PAD) and other cardiovascular disease, including the SilverHawk Plaque Excision System, a minimally-invasive catheter system that removes plaque to reopen narrowed or blocked arteries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full FoxHollow Technologies company profile →
Vivasure Medical
HQ: Ireland
Website
- Description: Provider of sutureless, fully absorbable vascular closure devices for large-bore vessel punctures in procedures such as TAVR, TEVAR, and EVAR. Products include the PerQseal Closure Device, a synthetic implant, and PerQseal+, an enhanced version with an improved bioabsorbable patch to manage more complex patient anatomies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vivasure Medical company profile →
Hotspur
HQ: United States
Website
- Description: Provider of catheter-based technologies to restore blood flow in patients with obstructed vessels, leveraging unique, groundbreaking technology to open blood vessels more efficiently and less invasively.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Hotspur company profile →
Anthos Therapeutics
HQ: United States
Website
- Description: Provider of biopharmaceutical therapies for cardiovascular and metabolic diseases, including Abelacimab, an investigational monoclonal antibody that inhibits Factor XI and XIa to provide anticoagulation with reduced bleeding risk for the prevention and treatment of arterial and venous thromboembolic events.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Anthos Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for diaDexus
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to diaDexus
2.2 - Growth funds investing in similar companies to diaDexus
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for diaDexus
4.2 - Public trading comparable groups for diaDexus
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →